 The goal of this clinical research study is to learn how effective the combination of chemotherapy including both panitumumab, Abraxane nab-paclitaxel, and carboplatin PNC and fluorouracil, epirubicin, and cyclophosphamide FEC used before surgery for the treatment of IBC is. The safety of PNC combination will also be studied. 